Europe Blood Collection Devices Market (2025-2030)
The Europe Blood Collection Devices Market was valued at $818.4 Million in 2025 and projected to reach to $1196.1 Million by 2030, representing a compound annual growth rate of CAGR 7.9%. Europe's blood collection devices market is positioned for sustained growth through 2030, driven by increasing prevalence of chronic diseases, expanding diagnostic testing infrastructure, and rising healthcare expenditure across EU member states.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Blood Collection Devices Market Trends and Insights
- This growth in Europe reflects increasing demand for advanced phlebotomy solutions driven by rising diagnostic testing volumes, aging populations, and stringent healthcare regulations across European nations.
- Europe's market expansion is supported by strong healthcare infrastructure, high adoption of safety-engineered devices, and continuous innovation in blood collection technology. The European blood collection devices market benefits from well-established medical device manufacturing capabilities and regulatory frameworks that prioritize patient and healthcare worker safety.
- Europe's emphasis on reducing needlestick injuries and bloodborne pathogen transmission has accelerated adoption of safety-engineered collection systems.
- Between 2025 and 2030, Europe is expected to see sustained growth driven by increased prevalence of chronic diseases, expanded screening programs, and investments in laboratory automation across hospitals and diagnostic centers throughout the region..
Key Market Statistics
- CAGR (2025-2030) CAGR 7.9%
- Market Size, 2025 ~USD 818.4 Million
- Forecast, 2030 ~USD 1196.1 Million
- Geography Europe
Europe Blood Collection Devices Market Overview
Market Valuation & Growth :
Europe's blood collection devices market is valued at $818.4 million in 2025 and is projected to reach $1,196.1 million by 2030, representing a robust 7.9% CAGR, outpacing the global average of 7.4%.
Aging Population Driving Demand :
Europe's aging demographic is significantly increasing diagnostic testing volumes and chronic disease management requirements, creating sustained demand for advanced phlebotomy solutions across healthcare facilities.
Regulatory Compliance & Standards :
Stringent European healthcare regulations and CE marking requirements are driving adoption of high-quality, compliant blood collection devices, benefiting manufacturers meeting these standards.
Germany Leads European Market :
Germany dominates Europe's blood collection devices market with a market size of $1,086.3 million, followed by France at $595.9 million, reflecting strong healthcare infrastructure and investment.
Europe Blood Collection Devices Market Dynamics
- The region's emphasis on patient safety and infection control standards continues to accelerate adoption of advanced collection technologies including safety-engineered devices and integrated collection systems.
- Healthcare modernization initiatives and aging populations across Western and Central Europe are expected to maintain strong demand momentum.
- Additionally, growing awareness of bloodborne pathogen risks among healthcare workers is propelling investment in innovative phlebotomy solutions that enhance occupational safety and operational efficiency..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Europe's blood collection devices market is valued at $818.4 million in 2025 and will reach $1,196.1 million by 2030, representing a 7.9% CAGR.
- Europe's strong regulatory environment and focus on occupational safety drive widespread adoption of safety-engineered blood collection systems.
- Aging European populations and rising chronic disease prevalence are increasing diagnostic testing demand, fueling market expansion.
- Europe's advanced healthcare infrastructure and laboratory automation investments support sustained growth in blood collection device adoption through 2030.
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
Europe Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BLOOD BANKS | 98.6 | 103.8 | 108.4 | 113.6 | 119.7 | 126.7 | 134.5 | 143.4 | 5.7 |
| DIAGNOSTIC & PATHOLOGY LABS | 132.9 | 141.9 | 150.3 | 159.7 | 170.8 | 183.2 | 197.3 | 213.3 | 7.3 |
| HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES | 317.4 | 341.9 | 365.1 | 391.1 | 421.4 | 455.6 | 494.4 | 538.3 | 8.1 |
| OTHER END USERS | 36.2 | 37.9 | 39.4 | 41 | 43 | 45.3 | 47.9 | 50.7 | 5.2 |
| TOTAL | 585 | 625.6 | 663.1 | 705.5 | 754.9 | 810.8 | 874 | 945.7 | 7.4 |
EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BLOOD BANKS | 392.3 | 413.7 | 432.3 | 453.5 | 478.5 | 506.7 | 538.6 | 574.6 | 5.9 |
| DIAGNOSTIC & PATHOLOGY LABS | 528.8 | 565.4 | 599.3 | 637.7 | 682.3 | 732.8 | 790 | 854.8 | 7.4 |
| HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES | 1263.4 | 1362.3 | 1455.9 | 1561.5 | 1683.9 | 1822.5 | 1979.5 | 2157.7 | 8.2 |
| OTHER END USERS | 143.9 | 150.9 | 157 | 163.8 | 172 | 181.2 | 191.6 | 203.4 | 5.3 |
| TOTAL | 2328.3 | 2492.3 | 2644.5 | 2816.5 | 3016.7 | 3243.2 | 3499.6 | 3790.4 | 7.5 |
Target Audience
- Medical Device Manufacturers : Manufacturers need Europe-specific market data to develop localized product strategies, identify growth opportunities in high-performing countries like Germany and France, and optimize market penetration.
- Healthcare Procurement Teams : Hospital and clinic procurement professionals require market insights to benchmark pricing, evaluate supplier options, and make cost-effective purchasing decisions for blood collection devices.
- Investment & Private Equity Firms : Investors evaluating opportunities in European healthcare need detailed market analysis to assess growth potential, identify acquisition targets, and understand regional market dynamics and valuations.
- Healthcare Consultants & Advisors : Consulting firms advising healthcare organizations and medical device companies require comprehensive European market data to support strategic recommendations and competitive positioning.
- Regulatory & Compliance Officers : Compliance professionals need region-specific regulatory insights and market standards to ensure product alignment with European healthcare requirements and market access criteria.
Key Companies in the Europe Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 1086.3 Million |
| France | USD 595.9 Million |
| UK | USD 161.1 Million |
| Italy | USD 109.5 Million |
| Spain | USD 95.9 Million |
| Rest Of Europe | USD 299.8 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Insights : Access detailed market sizing and growth projections for Germany, France, UK, Italy, Spain, and other European nations to identify high-opportunity markets for expansion and investment.
- Competitive Landscape Analysis : Understand market dynamics, key players, and competitive positioning specific to Europe's blood collection devices sector to inform strategic planning and market entry strategies.
- Regulatory & Compliance Framework : Gain insights into European healthcare regulations, CE marking requirements, and compliance standards that impact product development, market access, and competitive advantage.
- Growth Driver Identification : Identify region-specific growth catalysts including aging populations, diagnostic testing trends, healthcare infrastructure investments, and safety regulation changes driving market expansion.
- Forecast-Driven Decision Making : Leverage 5-year market forecasts and CAGR projections to make informed decisions on product launches, partnerships, and resource allocation across European markets.
Frequently asked questions
What is the current size of Europe's blood collection devices market?
Europe's blood collection devices market is valued at $818.4 million in 2025 and is expected to grow to $1,196.1 million by 2030.
What is the projected growth rate for blood collection devices in Europe?
Europe's blood collection devices market is projected to grow at a compound annual growth rate of 7.9% from 2025 to 2030.
What factors are driving growth in Europe's blood collection devices market?
Growth in Europe is driven by aging populations, increased diagnostic testing volumes, stringent safety regulations, adoption of safety-engineered devices, and investments in laboratory automation.
How does Europe's regulatory environment impact blood collection devices?
Europe's strict regulatory frameworks prioritize occupational safety and infection control, mandating safety-engineered collection systems that reduce needlestick injuries and bloodborne pathogen transmission.
Which European healthcare trends support blood collection device demand?
Rising chronic disease prevalence, expanded screening programs, aging demographics, and laboratory automation investments across European hospitals and diagnostic centers support sustained device demand.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- Canada Blood Collection Devices Market
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
- China Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
